Search Results

Data Presented From Mercator MedSystems' DANCE Trial

February 8, 2017—Mercator MedSystems, Inc. announced that the National Coprincipal Investigators of the company's DANCE trial recently presented comprehensive 13-month data.

Results Published From SAVE-US IDE Study of Bluegrass Vascular’s Surfacer System

July 16, 2020—Bluegrass Vascular Technologies announced that the results of its prospective, multicenter SAVE-US study were published online by Principal Investigator Mahmood Razavi, MD, et al in The Journal of Vascular Access.

Veniti Begins VIRTUS Trial for Its Vici Venous Stent System in the US

December 1, 2014—Veniti, Inc. announced that it has enrolled the first United States patients in the VIRTUS trial of the Veniti Vici venous stent system.

Vibrato’s LimbSonic Wearable Ultrasound Therapy Device Studied for PAD

October 31, 2023—The PRELUDE early feasibility study evaluated therapeutic ultrasound (TUS) with the LimbSonic device (Vibrato, Inc.) to increase perfusion for the treatment of peripheral artery disease (PAD).

Philips’ Duo Venous Stent System Studied in VIVID Trial at 24 Months

November 3, 2024—The 24-month outcomes from the VIVID clinical trial, which evaluated the safety and efficacy of the Duo venous stent system (Royal Philips) for the treatment of patients with nonmalignant iliofemoral occlusive disease, have been presented.

FDA Clears ReFlow Medical's Wingman35 Crossing Catheter

October 23, 2014—ReFlow Medical, Inc. announced US Food and Drug Administration (FDA) marketing clearance of the company’s Wingman35 crossing catheter.

Spartan Micro’s Center Wire Receives FDA Clearance

April 21, 2022—Spartan Micro, Inc. announced it has received FDA 510(k) clearance for the Spartan Center Wire, which is designed to provide distal fixation during access, resolving issues with free floating wires, risk of perforation, and reducing the need for additional surgeons (ie, hands to maintain access).